Search

Search Constraints

You searched for: Author/Creator Zeng, Liyan

Search Results

8. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Issue 1 (1st January 2021)